136 related articles for article (PubMed ID: 36919404)
1. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children.
Benson JW; Hraska V; Scott JP; Stuth EAE; Yan K; Zhang J; Niebler RA
World J Pediatr Congenit Heart Surg; 2023 May; 14(3):282-288. PubMed ID: 36919404
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
Guzzetta NA; Szlam F; Kiser AS; Fernandez JD; Szlam AD; Leong T; Tanaka KA
Br J Anaesth; 2014 Feb; 112(2):319-27. PubMed ID: 24193321
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII for the Management of Bleeding With Cardiac Surgery.
Katz A; Ahuja T; Arnouk S; Lewis TC; Marsh K; Papadopoulos J; Merchan C
J Intensive Care Med; 2022 Feb; 37(2):231-239. PubMed ID: 33402016
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients.
Faraoni D; Guindi A; Ankola AA; Resheidat A; Binsalamah Z; Teruya J; Savorgnan F; Vener DF
J Cardiothorac Vasc Anesth; 2024 Feb; 38(2):388-393. PubMed ID: 38129208
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
[TBL] [Abstract][Full Text] [Related]
7. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass.
Nellenbach K; Guzzetta NA; Brown AC
J Thromb Haemost; 2018 Nov; 16(11):2159-2167. PubMed ID: 30182421
[TBL] [Abstract][Full Text] [Related]
11. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
Mehringer SL; Klick Z; Bain J; McNeely EB; Subramanian S; Pass LJ; Drinkwater D; Reddy VS
Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
[TBL] [Abstract][Full Text] [Related]
12. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.
Downey L; Brown ML; Faraoni D; Zurakowski D; DiNardo JA
Anesth Analg; 2017 May; 124(5):1431-1436. PubMed ID: 28319507
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
Godier A; Miclot A; Le Bonniec B; Durand M; Fischer AM; Emmerich J; Marchand-Leroux C; Lecompte T; Samama CM
Anesthesiology; 2012 Jan; 116(1):94-102. PubMed ID: 22042412
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery.
Niles SD; Burkhart HM; Duffey DA; Buhrman K; Burzynski J; Holt DW
J Extra Corpor Technol; 2008 Dec; 40(4):241-8. PubMed ID: 19192753
[TBL] [Abstract][Full Text] [Related]
16. Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia.
Mazzeffi M; Beller J; Strobel R; Norman A; Wisniewski A; Smith J; Fonner CE; McNeil J; Speir A; Singh R; Tang D; Quader M; Yarboro L; Teman N
J Cardiothorac Vasc Anesth; 2024 Mar; 38(3):660-666. PubMed ID: 38220518
[TBL] [Abstract][Full Text] [Related]
17. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
Ekert H; Brizard C; Eyers R; Cochrane A; Henning R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):389-95. PubMed ID: 16788315
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin Complex Concentrate vs Plasma for Post-Cardiopulmonary Bypass Coagulopathy and Bleeding: A Randomized Clinical Trial.
Smith MM; Schroeder DR; Nelson JA; Mauermann WJ; Welsby IJ; Pochettino A; Montonye BL; Assawakawintip C; Nuttall GA
JAMA Surg; 2022 Sep; 157(9):757-764. PubMed ID: 35767271
[TBL] [Abstract][Full Text] [Related]
20. Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit.
Le Saché F; Le Bonniec B; Gaussem P; Dizier B; Tagzirt M; Godier A; Emmerich J; Samama CM
Br J Anaesth; 2012 Apr; 108(4):586-93. PubMed ID: 22258204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
